Development, optimization and evaluation of electrospun nanofibers: Tool for targeted vaginal delivery of antimicrobials against urinary tract infections

Current Drug Delivery

Volumn 13, Issue 5, 2016, Pages 754-763

  Kaur, Rajwinder ^a   Garg, Tarun ^a   Goyal, Amit K ^a   Rath, Goutam ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Electrospinning; Fluconazole; Nanofiber; Vaginal candidiasis

Indexed keywords

ANTIINFECTIVE AGENT; NANOFIBER; POLYLACTIC ACID; DRUG CARRIER; FLUCONAZOLE; POLYESTER; POLYLACTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CFU COUNTING; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; ELECTROSPINNING; FEMALE; KIDNEY; MAINTENANCE DRUG DOSE; NONHUMAN; ORGAN DISTRIBUTION; PRIORITY JOURNAL; RAT; URINARY TRACT INFECTION; VAGINAL DELIVERY; ADHESION; ANIMAL; BACTERIAL COUNT; CHEMISTRY; DIFFERENTIAL SCANNING CALORIMETRY; DISEASE MODEL; ESCHERICHIA COLI INFECTIONS; INTRAVAGINAL DRUG ADMINISTRATION; METABOLISM; MICROBIOLOGY; NANOMEDICINE; PHARMACEUTICS; PROCEDURES; SCANNING ELECTRON MICROSCOPY; SOLUBILITY; TENSILE STRENGTH; TISSUE DISTRIBUTION; URINARY TRACT INFECTIONS; VAGINOSIS, BACTERIAL; X RAY CRYSTALLOGRAPHY;

ADHESIVENESS; ADMINISTRATION, INTRAVAGINAL; ANIMALS; ANTI-BACTERIAL AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; COLONY COUNT, MICROBIAL; CRYSTALLOGRAPHY, X-RAY; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG COMPOUNDING; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUCONAZOLE; KIDNEY; MICROSCOPY, ELECTRON, SCANNING; NANOFIBERS; NANOMEDICINE; POLYESTERS; RATS; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; TENSILE STRENGTH; TISSUE DISTRIBUTION; URINARY TRACT INFECTIONS; VAGINOSIS, BACTERIAL;

EID: 84978280229     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/1567201812666150212123348     Document Type: Article

References (16)

1. Kunin, C. M. Urinary tract infections. Detection, prevention, and management, 5th ed.; Williams & Wilkins: Baltimore, 1997.
2. Foxman, B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am. J. Med., 2002, 113(1), 5-13.
3. Valiquette, L. Urinary tract infections in women. Can. J. Urol., 2001, 8, 6-12.
4. Lee, J. B.; Neild, G. H. Urinary tract infection. Medicine, 2007, 35(8), 423-428.
5. Malinverni, R. Urinary tract infections and antibiotic resistance. Ther. Ums Revue Therap, 2002, 59(1), 31-35.
6. Brumfitt, W.; Hamilton-Miller, J. Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience. J. Antimicrob. Chemother., 1998, 42(3), 363-371.
7. Lala, N. L.; Ramaseshan, R.; Bojun, L.; Sundarrajan, S.; Barhate, R.; Ying-jun, L.; Ramakrishna, S. Fabrication of nanofibers with antimicrobial functionality used as filters: protection against bacterial contaminants. Biotechnol. Bioeng., 2007, 97(6), 1357-1365.
8. Zaman, M. A.; Martin, G. P.; Rees, G. D. Mucoadhesion, hydration and rheological properties of non-aqueous delivery systems (NADS) for the oral cavity. J. Dent., 2008, 36(5), 351-359.
9. Boddupalli, B. M.; Mohammed, Z. N.; Nath, R. A.; Banji, D. Mucoadhesive drug delivery system: An overview. J. Adv. Pharm. Tech. Res., 2010, 1(4), 381-390.
10. Verreck, G.; Chun, I.; Peeters, J.; Rosenblatt, J.; Brewster, M. E. Preparation and characterization of nanofibers containing amorphous drug dispersions generated by electrostatic spinning. Pharm. Res., 2003, 20(5), 810-817.
11. Esses, S.; Bostford, D.; Huler, R.; Rauschning, W. Surgical anatomy of the sacrum: a guide for rational screw fixation. Spine, 1991, 16(6S), S283-S288.
12. Gray, H. Anatomy of the human body, 20th ed.; Lea & Febiger: Philadelphia, 1918.
13. Kulkarni, R.; Moore, E.; Hegyeli, A.; Leonard, F. Biodegradable poly (lactic acid) polymers. J. Biomed. Mater. Res., 1971, 5(3), 169-181.
14. Kahlmeter, G. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO-SENS study. Int. J. Antimicrob. Agents, 2003, 22, 49-52.
15. Verreck, G.; Chun, I.; Rosenblatt, J.; Peeters, J.; Dijck, A. V.; Mensch, J.; Noppe, M.; Brewster, M. E. Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, nonbiodegradable polymer. J. Control. Release, 2003, 92(3), 349-360.
16. Ishii, D.; Ying, T. H.; Mahara, A.; Murakami, S.; Yamaoka, T.; Lee, W. K.; Iwata, T. In vivo tissue response and degradation behavior of PLLA and stereocomplexed PLA nanofibers. Biomacromolecules, 2008, 10(2), 237-242.